Alison Bailey, MD, FACC

Erlanger Health System
University of Tennessee College of Medicine
Chattanooga, TN

James L. Januzzi, MD

Associate Professor of Medicine
Harvard Medical School
Director, Cardiac Intensive Care Unit
Massachusetts General Hospital
Boston, Massachusetts

Michelle Kittleson, MD, FACC

Melissa Magwire, RN, MSN, CDE

Muthiah Vaduganathan, MD, MPH

Accredited by

American College of Cardiology

Course Description

Upon completion of this program, you should be able to:
- Evaluate the relevant clinical trials that impact the emerging indications of SGLT2 inhibitors.
- Identify the mechanism of action and resulting indications for SGLT2 inhibitors.
- Apply practical approaches to patient selection and clinical implications for utilizing SGTL2 inhibitors in practice.

Activity Details

Credit Types:CME / MOC / CNE
Credit Amount:1.50 Credits
Release Date:2020-Oct-15
Expiration Date:2021-Oct-15
Registration Required:Yes

Suggest a CME Activity

Please provide below the URL and description of an activity you would like to add to OpenCME. You are welcome to add activities as often as you like. To prevent spam or other abuse, activities are reviewed by our editorial team before appearing on OpenCME.

OpenCME for Publishers

Please use the form below if you would like to offer your website visitors high-quality CME content by adding the OpenCME Widget to one or more of your pages.

Send Email to a Colleague

To share this activity with one or more colleagues, enter their e-mail addresses below. To include a personal message, simply overwrite the suggested text below.

(So your recipient knows it's from you.)
Enter multiple recipients separated by a space.
Optionally, replace/modify in the box above the message that will be sent to your colleague(s) with a link to download this app.